GAITHERSBURG, Maryland (Reuters) - Pfizer Inc.'s pain reliever Celebrex should be approved for treating rheumatoid arthritis in children despite uncertainty about the risks of long-term use, U.S.

Two of the most widely used new drugs for arthritis may increase a patient’s risk of heart attack and stroke and probably should not be used by people who already are at high risk for cardiovascular ...

Back in 2004, a popular arthritis drug called Vioxx was pulled off the market when studies showed daily long-term use could increase the risk of heart attack, stroke and death. “This was one of the ...

SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...

GAITHERSBURG, Md. — Pfizer Inc. should get American approval to market its Celebrex arthritis-pain pill for use in children because the benefits outweigh the risks, a Food and Drug Administration ...

BOSTON — The blockbuster arthritis drug Celebrex doesn’t protect the stomach from dangerous bleeding ulcers as well as thought, a study published today suggests. Celebrex and two similar new ...

The FDA’s Arthritis Drugs Advisory Committee has voted to recommend approval of Pfizer’s Celebrex for use in juvenile rheumatoid arthritis, despite long-term safety concerns. They recommended that, if ...

NEW ORLEANS — A new study gives some reassurance to arthritis sufferers who want pain relief but are worried about side effects. It finds that Celebrex, a drug similar to ones withdrawn 12 years ago ...

The blockbuster arthritis drug Celebrex doesn’t protect the stomach from dangerous bleeding ulcers as well as thought, a study suggests. Celebrex and two similar new anti-inflammatory drugs are ...

Pfizer Inc. may fall short in convincing federal regulators that its painkiller Celebrex should receive expanded approval to treat children with a devastating form of arthritis, according to documents ...

The blockbuster arthritis drug Celebrex doesn’t protect the stomach from dangerous bleeding ulcers as well as thought, a study suggests. Celebrex and two similar new anti-inflammatory drugs are ...